Skip to content
Review Open access

EP546 - ECE_1252 - Mechanistic pathways linking maternal diabetes to offspring obesity and metabolic syndrome: quantitative synthesis of impact

Aug 2026 · European Journal of Endocrinology · Vol 195 · 0 citations

TL;DR

Quantitative analysis reveals that fetal programming and adipose tissue development are the predominant mechanisms, but endocrine, epigenetic, and environmental factors also play significant roles, and underscore the need for mechanistic-based risk assessments in clinical practice to guide early interventions in at-risk children.

Abstract

Children born to mothers with diabetes—both gestational and pregestational—are at increased risk for obesity and metabolic syndrome later in life. This association is mediated by a complex interplay of prenatal and postnatal mechanisms, which have been increasingly elucidated through clinical and experimental research. Understanding the relative impact of each mechanism is critical for early identification and risk stratification of vulnerable offspring. To systematically evaluate and quantify the mechanisms by which maternal diabetes predisposes offspring to obesity and metabolic syndrome, and to determine their relative contributions based on published data. A comprehensive review was conducted of 40 studies published between 2000 and 2024 that addressed the biological and developmental mechanisms linking maternal diabetes to obesity and metabolic disorders in offspring. Mechanisms were grouped into five main categories: fetal programming via hyperglycemia and insulin exposure, altered adipose tissue development, endocrine and hormonal alterations, epigenetic imprinting, and postnatal influences including feeding behavior and microbiome changes. Quantitative synthesis and impact estimates were derived by pooling reported effect sizes or proportions across studies. Among the five categories of mechanisms identified, fetal programming emerged as the most impactful, accounting for approximately 30% of the total mechanistic contribution. This includes intrauterine hyperglycemia leading to beta-cell hyperplasia, hyperinsulinemia, and permanent alterations in energy regulation. Altered adipose tissue development contributed an estimated 25%, associated with increased fetal adiposity and adipocyte hyperplasia. Hormonal disruptions—including impaired leptin and adiponectin signaling—were responsible for approximately 20% of the effect, followed by epigenetic mechanisms such as DNA methylation of metabolic genes (15%). Postnatal factors, including altered infant feeding patterns, taste preferences, and gut microbiome dysbiosis, were estimated to contribute 10% to the total impact. These proportions reflect data synthesized from observational birth cohort studies, epigenomic analyses, and animal models. The predisposition to obesity and metabolic syndrome in offspring of diabetic mothers arises from a multifactorial process rooted in both prenatal and postnatal exposures. Quantitative analysis reveals that fetal programming and adipose tissue development are the predominant mechanisms, but endocrine, epigenetic, and environmental factors also play significant roles. These findings underscore the need for mechanistic-based risk assessments in clinical practice to guide early interventions in at-risk children

Read PDF

Similar papers

Open access Aug 2026

Maternal obesity programs offspring metabolic dysfunction via small extracellular vesicle-mediated epigenetic remodeling

It is shown that maternal circulating small extracellular vesicles crossed the placenta and delivered obesity-associated miRNAs to the fetal liver, with lasting consequences for insulin sensitivity in male offspring, and a transplacental sEV-miRNA-epigenetic axis is identified as a mediator of maternal obesity.

Hui-Chen Song, Dameng Li, Li-Na Ma et al. · 0 citations
Review Open access Sep 2026

Placental Pathophysiology and Developmental Programming of Adult Cardiometabolic Risk: A Narrative Review of Pregnancy Exposures

Longitudinal studies integrating maternal exposures, placental histopathology and molecular phenotypes, fetal organ development, childhood cardiometabolic trajectories and adult clinical outcomes are needed to determine whether, and under what circumstances, the placenta plays an intermediary role rather than merely se...

Eleftherios Panteris, Ioanna Kakatsaki, Kou-Kou Zoi et al. · 0 citations
Open access Sep 2026

Triglycerides and gestational diabetes mellitus: integrated clinical and genetic evidence linking LPL-related lipid metabolism

Gestational diabetes mellitus (GDM) is associated with adverse maternal and offspring outcomes, and disturbances in lipid metabolism may contribute to its metabolic pathophysiology. Elevated triglyceride (TG) levels have been consistently associated with GDM; however, it remains unclear whether this association i...

Yao Wang, Lihua Dong, Juan-Yu Ma et al. · 0 citations
Review Open access Aug 2026

Nutrigenomics and epigenetics in type 2 diabetes mellitus (T2DM) prevention – literature review

Introduction and Objective. Type 2 diabetes mellitus affects more than 500 million adults worldwide and continues to increase. Diet shapes molecular pathways regulating insulin sensitivity, inflammation and glucose metabolism. Nutrigenomics studies nutrient-gene interactions, while epigenetics focuses on reversible mec...

Natalia Kosińska, Maria Lucyna Lamorska, P. Gebuza et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.